An Open-Label, Long-Term Evaluation of the Safety and Efficacy of Avanafil in Men With Erectile Dysfunction.

Trial Profile

An Open-Label, Long-Term Evaluation of the Safety and Efficacy of Avanafil in Men With Erectile Dysfunction.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2013

At a glance

  • Drugs Avanafil (Primary)
  • Indications Erectile dysfunction
  • Focus Registrational; Therapeutic Use
  • Sponsors VIVUS
  • Most Recent Events

    • 01 Apr 2013 Results published in the International Journal of Clinical Practice.
    • 05 Dec 2011 Results were presented at the 2011 European Society of Sexual Medicine Meeting
    • 15 Nov 2011 Further analyses were presented at the 2011 Sexual Medicine Society of North America annual meeting, according to a VIVUS media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top